Haleon PLC (NYSE:HLN)
$ 8.38 -0.08 (-0.95%) Market Cap: 38.26 Bil Enterprise Value: 49.20 Bil PE Ratio: 27.37 PB Ratio: 1.80 GF Score: 27/100

HALEON PLC at Exane BNP Paribas European CEO Conference Transcript

Jun 10, 2021 / NTS GMT
Jeff Stent
Exane BNP Paribas - Analyst

Over to you, Brian.

Brian McNamara
GSK Consumer Healthcare - CEO

Yes. Thanks so much, Jeff, for that introduction. I appreciate that. So listen, I'll leave it to all of you at your own time to read the customary disclaimer. So it's great to be here today to talk to you about GSK Consumer Healthcare, the world leader in consumer healthcare, competing in GBP130 billion market that's been growing at about 3.5% a year.

And to talk to you about our exciting journey to separation and listing, which is scheduled to happen in mid-2022. We have a great opportunity ahead of us. At the time of listing, we'll be the first and only listed company 100% focused on consumer health. And with that, we bring a unique combination of a scientific heritage and capability that comes from being part of a pharma company with strong FMCG skills that we've built over time.

Now, this really comes to life in our oral health business, where you see Sensodyne, which is our largest brand, has been able to grow double digits over the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot